Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20.8M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
19.2M
-
Shares change
-
+5.65M
-
Total reported value, excl. options
-
$67.3M
-
Value change
-
+$19.6M
-
Put/Call ratio
-
0.03
-
Number of buys
-
41
-
Number of sells
-
-20
-
Price
-
$3.50
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q4 2017
77 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share as of Q4 2017.
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.2M shares
of 20.8M outstanding shares and own 92.29% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (2.55M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.5M shares), HIGHBRIDGE CAPITAL MANAGEMENT LLC (2.3M shares), DIMENSIONAL FUND ADVISORS LP (940K shares), Vanguard Group Inc (857K shares), Rubric Capital Management LP (800K shares), Tekla Capital Management LLC (744K shares), Sessa Capital IM, L.P. (639K shares), MORGAN STANLEY (579K shares), and FMR LLC (550K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.